Medtronic InSync III
This article was originally published in The Gray Sheet
Executive Summary
Resynchronization device incorporating activation flexibility that allows physicians to control beating action of the right/left sides of the heart independently and heart failure specific diagnostic capabilities is launched in Europe, Canada and the Middle East, Medtronic announces June 5. A PMA for the InSync is currently pending at FDA